Theradigm-HPV immunotherapeutic vaccine: Began Phase I/II trial

Cytel Corp. (CYTL), San Diego Product: Theradigm-HPV immunotherapeutic vaccine, which stimulates killer T cells to recognize and eliminate cancers bearing the MAGE-3 protein Indication: Cervical cance...